Why Abzena?
Our focused approach.
Uncertainty in the global climate is reshaping the bio/pharma industry’s supply chain strategies. In a recent interview with PharmTech, Joe Principe, Chief Commercial Officer at Abzena, discusses how legislative factors such as the BIOSECURE Act and potential tariffs are driving new approaches to ensure continuity of supply. Abzena will be exploring these topics further at DCAT Week 2025, March 17–20 in New York City.